Skip to main content

SAL 726 (Mycophenolate Mofetil 250 mg)

Pill with imprint SAL 726 is White, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Strides Arcolab Limited.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SAL 726

Mycophenolate Mofetil

SAL 726
250 mg
1.00 mm
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Strides Arcolab Limited
National Drug Code (NDC)
59762-0703 (Discontinued)
Inactive Ingredients
croscarmellose sodium, FD&C Red No. 3, ferric oxide yellow, gelatin, magnesium stearate, sodium lauryl sulfate, titanium dioxide, povidone k30, microcrystalline cellulose

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.